Css LLC Reata Pharmaceuticals Inc Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $200,525 - $605,605	-6,500 Reduced 46.76%	7,400 $672,000
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $307,885 - $585,329	13,900 New	13,900 $528,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $362,425 - $638,750	-17,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $422,100 - $693,000	17,500 New	17,500 $574,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $512,200 - $2.22 Million	-20,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $2 Million - $2.86 Million	20,000 New	20,000 $2.01 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.